OralMedic - Odontologia e estética facial

What OralMedic - Odontologia e estética facial does

ORALMEDIC® is a single-product, over-the-counter consumer health treatment for mouth ulcers and canker sores, manufactured and marketed by EPIEN Medical, Inc., a privately held Minnesota corporation headquartered in St Louis Park, MN with manufacturing in White Bear Lake, MN. The product targets adults and children aged 12 and older who suffer from recurrent or acute aphthous ulcers, offering a one-time, single-application treatment as an alternative to multi-application competitors.

The core technology is HYBENX®, a proprietary formulation that rapidly dehydrates the top layer of tissue at the ulcer site to form a white eschar — a scab-like protective barrier that shields the wound and supports natural healing, typically within 3–5 days. The ORALMEDIC® trademark is registered to EPIEN, and the product is sold in a single SKU format with no companion offerings, add-ons, or sub-products.

Commercially, EPIEN pursues a direct-to-consumer brand motion but does not sell directly to end users; instead, it relies on a network of regional distributor partners that manage retail and reseller relationships within assigned territories. Active distribution covers eight markets across Oceania (Australia, New Zealand), EMEA (Europe/Middle East/Africa via Chemipal Ltd., plus Israel, Turkey, and Italy), North America (Canada), and Asia-Pacific (Hong Kong), with Mexico pending COFEPRIS regulatory approval. The product is not FDA-approved and is therefore not sold in the United States. End-customer marketing runs through the oralmedic.com website and organic social channels (Facebook, Twitter, YouTube, LinkedIn), emphasizing dentist recommendation and clinical proof points.

Name

OralMedic - Odontologia e estética facial

Legal name

EPIEN Medical, Inc.

Website

https://oralmedic.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

EPIEN Medical, Inc. manufactures ORALMEDIC®, a one-time OTC mouth ulcer treatment using HYBENX® technology, distributed via regional partners across Australia, New Zealand, EMEA, Canada, and Hong Kong for adults and children aged 12 and older.

Ownership category

akta.pro rank

Product category

Consumer Oral Healthcare Products

NAICS

Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening) (CRADAMAA)

akta.pro secondary industries

Pain Relief & Anti-Inflammatory (Analgesics) (HLAIADAA), First Aid & Wound Care (HLAIADAM)

Keywords

• Mouth ulcer treatment
• Oral care products
• Canker sore remedy
• OTC oral medication
• Consumer healthcare products

Headquarters

HQ city

St Louis Park

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure

Revenue model

1. One-time Treatment Product Sales: ORALMEDIC generates revenue through the sale of single-use treatment kits for mouth ulcers. The product is designed for one-time application per ulcer, providing immediate and long-lasting pain relief. Distribution occurs through regional distributor partners across multiple international markets.

Go-to-market motion1 record

Distribution channels7 records

Marketing channels5 records

Core offering

ORALMEDIC® is a single-use, over-the-counter oral treatment kit for mouth ulcers and canker sores. Applied once via a topical applicator, it uses HYBENX® technology to dehydrate the top layer of ulcer tissue and form a protective white eschar barrier, providing rapid pain relief and supporting natural healing typically within 3–5 days. It is sold to adult and adolescent (12+) consumers through regional distributor partners.

Product overview

ORALMEDIC® is a single, unified consumer health product — a one-time treatment for mouth ulcers and canker sores. The product uses HYBENX® technology to create a protective barrier over the ulcer, providing immediate pain relief and supporting natural healing typically within 3–5 days. There are no add-on modules, sub-products, or companion offerings; the portfolio consists of this single treatment product designed for adults and children aged 12 and older.

Differentiator

Problem solved

Functional benefit

Products and services

• ORALMEDIC® A single-use, over-the-counter oral treatment kit for mouth ulcers and canker sores, applied once via a topical applicator to form a protective white eschar barrier that delivers rapid, long-lasting pain relief and supports natural healing within 3–5 days; designed for adults and children aged 12 and older.

Quantifiable outcome

• Healing typically occurs within 3-5 days

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Seven partnerships are on record, tiered core and minor.

• Marketing Brokers Australia Pty Ltd.coreChannel Partner/ Reseller/ DistributorAuthorized distributor for ORALMEDIC products in Australia. Located at 111 Princes Highway, NSW 2217, Australia. Operates website oralmedic.com.au for Australian market distribution.
• Marketing Brokers New Zealand Ltd.coreChannel Partner/ Reseller/ DistributorAuthorized distributor for ORALMEDIC products in New Zealand. Located at 169 Pilkington Rd., Auckland 1072, New Zealand. Operates website oralmedic.co.nz for New Zealand market distribution.
• Chemipal Ltd.coreChannel Partner/ Reseller/ DistributorMain distributor for ORALMEDIC in Europe, Middle East, and Africa, as well as Israel. Located at 44 Giborei Israel Street, Poleg Industrial Zone, Natanya, Israel 4250432. Operates website chemipal.co.il.
• Casel Ecz.minorChannel Partner/ Reseller/ DistributorAuthorized distributor for ORALMEDIC in Turkey. Located at Talatpaşa Mah. Pazaryolu Cad., No: 4 Casel Plaza, 34513 Esenyurt/Istanbul. Operates website casel.com.
• E.fa.s SpaminorChannel Partner/ Reseller/ DistributorAuthorized distributor for ORALMEDIC in Italy. Located at Via Malcantone 3, 40011 Anzola dell'Emilia (BO). Operates website efasspa.com.
• 16474039 Canada Inc.coreChannel Partner/ Reseller/ DistributorAuthorized distributor for ORALMEDIC in Canada. Located at 54 Carnforth Rd, Toronto, Ontario, Canada ON M4A 2K7. Operates website oralmedic.ca.
• Sante Healthcare Alliance International LimitedminorChannel Partner/ Reseller/ DistributorAuthorized distributor for ORALMEDIC in Hong Kong. Located at Unit 2209-10, 22/F, APEC Plaza, 49 Hoi Yuen Road, Kwun Tong, Kowloon, Hong Kong. Operates website santecare.com.hk.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Haleon: GSK Consumer Healthcare spin-out that markets Bonjela outside the US, a leading OTC oral ulcer gel. Comparable as a global consumer healthcare major with a directly competing oral ulcer franchise, albeit within a much broader self-care portfolio.
• Colgate-Palmolive: Markets Orabase and a broad oral care portfolio including toothpaste, mouthwash and treatments. Comparable as a major oral care CPG player with OTC-adjacent products for mouth lesions, though its oral ulcer offerings are a small slice of a much wider portfolio.
• Prestige Consumer Healthcare: OTC consumer healthcare company with a portfolio that has historically included oral care and oral pain relief brands. Comparable as a multi-brand OTC platform that competes for retail shelf space and consumer spend in the oral care/OTC category.
• Reckitt Benckiser: Owns Bonjela in certain markets and a portfolio of OTC consumer health brands. Comparable as a multinational OTC player with an oral ulcer treatment brand competing in the same end-aisle category.

Direct peers

• Sunstar (GUM brand): GUM is a specialty oral care brand covering toothpastes, mouth rinses and inter-dental products, with adjacencies in oral irritation/ulcer care. Comparable as a focused oral-care CPG brand that competes for the same canker-sore-prone consumer.
• Blistex: Privately held OTC brand specializing in lip and oral care, including treatments for cold sores and oral discomfort. Comparable as a focused OTC oral-care specialist operating in adjacent lesion/pain treatment categories.
• DenTek (Dr. Fresh): Specialty oral care brand offering picks, floss, interdental products and oral pain/ulcer products. Comparable as a small-to-mid sized oral care specialist with overlapping OTC oral treatment SKUs.
• Church & Dwight: Owner of Orajel, Anbesol and Kank-A — leading OTC oral pain relief and canker sore treatment brands sold in mass retail. Directly comparable to ORALMEDIC as a consumer-facing OTC oral ulcer/pain treatment, but at vastly greater scale and with full US distribution.
• Dentek Oral Care (Innovation Laboratories): Brand portfolio covering oral pain relief, canker sore management and interdental care. Comparable as a direct competitor offering OTC oral lesion treatments in mass retail channels.

Emerging players

• Health Enterprises: Smaller specialty maker of oral care and personal health products. Comparable as a niche OTC oral-care player with overlapping product categories, though at a smaller scale and broader portfolio breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/oralmedic---odontologia-e-est%C3%A9tica-facial

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OralMedic - Odontologia e estética facial